BioSpace Collaborative

Academic/Biomedical Research
News & Jobs
Biotechnology and Pharmaceutical Channel Medical Device and Diagnostics Channel Clinical Research Channel BioSpace Collaborative    Job Seekers:  Register | Login          Employers:  Register | Login  

NEWSLETTERS
Free Newsletters
Archive
My Subscriptions

NEWS
News by Subject
News by Disease
News by Date
PLoS
Search News
Post Your News
JoVE

CAREER NETWORK
Job Seeker Login
Most Recent Jobs
Search Jobs
Post Resume
Career Fairs
Career Resources
For Employers

HOTBEDS
Regional News
US & Canada
  Biotech Bay
  Biotech Beach
  Genetown
  Pharm Country
  BioCapital
  BioMidwest
  Bio NC
  BioForest
  Southern Pharm
  BioCanada East
  C2C Services & Suppliers™
Europe
Asia

DIVERSITY

PROFILES
Company Profiles

INTELLIGENCE
Research Store

INDUSTRY EVENTS
Research Events
Post an Event
RESOURCES
Real Estate
Business Opportunities

 News | News By Subject | News by Disease News By Date | Search News
Get Our Industry eNewsletter FREE email:    
   

Former Purdue Pharma L.P. Execs Lose Federal Appeal


7/30/2012 7:30:35 AM

A federal appeals court upheld HHS' decision to exclude three former Purdue Pharma executives from participating in federal healthcare programs such as Medicare and Medicaid. Michael Friedman, Paul Goldenheim and Howard Udell, executives of what was then called Purdue Frederick, pleaded guilty in 2007 for failing to prevent the company's fraudulent marketing of the painkiller OxyContin. In its opinion (PDF), the U.S. Court of Appeals for the District of Columbia Circuit Court ruled that the executives can be excluded from federal healthcare programs for their misdemeanor misbranding convictions.


   

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES
 

//-->